1 1 Oncosem UK Limited 14413695 false 2023-11-01 2024-10-31 2024-10-31 The principal activity of the company is Production of equipment and medical devices used in cancer treatment Digita Accounts Production Advanced 6.30.9574.0 true 14413695 2023-11-01 2024-10-31 14413695 2024-10-31 14413695 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 14413695 bus:Micro-entities 2023-11-01 2024-10-31 14413695 bus:AuditExemptWithAccountantsReport 2023-11-01 2024-10-31 14413695 bus:FilletedAccounts 2023-11-01 2024-10-31 14413695 bus:SmallCompaniesRegimeForAccounts 2023-11-01 2024-10-31 14413695 bus:RegisteredOffice 2023-11-01 2024-10-31 14413695 bus:Director1 2023-11-01 2024-10-31 14413695 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 14413695 bus:Agent1 2023-11-01 2024-10-31 14413695 countries:AllCountries 2023-11-01 2024-10-31 14413695 2022-10-12 2023-10-31 14413695 2023-10-31 14413695 core:CurrentFinancialInstruments core:WithinOneYear 2023-10-31 xbrli:pure iso4217:GBP

Registrar

Registration number: 14413695

Oncosem UK Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 October 2024

 

Oncosem UK Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3

 

Oncosem UK Limited

Company Information

Director

A M N I Namroqa

Registered office

3 Warners Mill
Silks Way
Braintree
Essex
CM7 3GB

Accountants

Lambert Chapman LLP
Chartered accountants3 Warners Mill
Silks Way
Braintree
Essex
CM7 3GB

 

Oncosem UK Limited

(Registration number: 14413695)
Balance Sheet as at 31 October 2024

2024
£

2023
£

Current assets

45,760

475

Prepayments and accrued income

4,000

-

Creditors: Amounts falling due within one year

(48,562)

-

Total assets less current liabilities

1,198

475

Accruals and deferred income

(1,175)

(825)

 

23

(350)

Capital and reserves

23

(350)

For the financial year ended 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 21 March 2025
 

.........................................

A M N I Namroqa
Director

 

Oncosem UK Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
3 Warners Mill
Silks Way
Braintree
Essex
CM7 3GB
United Kingdom

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).